nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—nerve—migraine	0.0564	0.208	CbGeAlD
Amcinonide—ANXA1—Prostaglandin Synthesis and Regulation—EDNRA—migraine	0.0422	0.0597	CbGpPWpGaD
Amcinonide—ANXA1—neck—migraine	0.0317	0.117	CbGeAlD
Amcinonide—ANXA1—trigeminal ganglion—migraine	0.0273	0.101	CbGeAlD
Amcinonide—ANXA1—cardiovascular system—migraine	0.0198	0.0728	CbGeAlD
Amcinonide—NR3C1—nerve—migraine	0.0196	0.0722	CbGeAlD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—migraine	0.0173	0.0245	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—MEF2D—migraine	0.0168	0.0238	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—HTR2B—migraine	0.0165	0.0234	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—HTR1D—migraine	0.0148	0.021	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.0148	0.0209	CbGpPWpGaD
Amcinonide—ANXA1—head—migraine	0.0134	0.0493	CbGeAlD
Amcinonide—ANXA1—nervous system—migraine	0.0127	0.0468	CbGeAlD
Amcinonide—ANXA1—GPCR ligand binding—CALCRL—migraine	0.0124	0.0175	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—RAMP1—migraine	0.0124	0.0175	CbGpPWpGaD
Amcinonide—ANXA1—central nervous system—migraine	0.0122	0.045	CbGeAlD
Amcinonide—ANXA1—cerebellum—migraine	0.0119	0.044	CbGeAlD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.0118	0.0167	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—PGR—migraine	0.0116	0.0164	CbGpPWpGaD
Amcinonide—NR3C1—neck—migraine	0.011	0.0406	CbGeAlD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.011	0.0155	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—BDNF—migraine	0.0105	0.0149	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—NPS—migraine	0.0102	0.0145	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—TAC1—migraine	0.0102	0.0145	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—NPS—migraine	0.0101	0.0143	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—TAC1—migraine	0.0101	0.0143	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—HTR2C—migraine	0.01	0.0142	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—EDNRA—migraine	0.00975	0.0138	CbGpPWpGaD
Amcinonide—ANXA1—brain—migraine	0.00969	0.0357	CbGeAlD
Amcinonide—ANXA1—Peptide ligand-binding receptors—EDNRA—migraine	0.00963	0.0136	CbGpPWpGaD
Amcinonide—NR3C1—trigeminal ganglion—migraine	0.0095	0.035	CbGeAlD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—ATP1A3—migraine	0.00938	0.0133	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.00914	0.0129	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.00914	0.0129	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—PGR—migraine	0.00913	0.0129	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—HTR1B—migraine	0.00898	0.0127	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR1D—migraine	0.00897	0.0127	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.00897	0.0127	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00896	0.0127	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00872	0.0123	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—HTR1A—migraine	0.00864	0.0122	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—MEF2D—migraine	0.00844	0.0119	CbGpPWpGaD
Amcinonide—NR3C1—brainstem—migraine	0.00841	0.031	CbGeAlD
Amcinonide—ANXA1—GPCR ligand binding—HTR2B—migraine	0.00834	0.0118	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR3A—migraine	0.00798	0.0113	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.00716	0.0101	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00714	0.0101	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—FOS—migraine	0.00711	0.0101	CbGpPWpGaD
Amcinonide—Fluticasone Propionate—PGR—migraine	0.00704	0.313	CrCbGaD
Amcinonide—ANXA1—GPCR downstream signaling—CALCRL—migraine	0.00698	0.00988	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—RAMP1—migraine	0.00698	0.00988	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00687	0.00973	CbGpPWpGaD
Amcinonide—NR3C1—cardiovascular system—migraine	0.00686	0.0253	CbGeAlD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00677	0.00958	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00677	0.00958	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00664	0.0094	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—ESR1—migraine	0.00648	0.00917	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.00646	0.00914	CbGpPWpGaD
Amcinonide—Betamethasone—PGR—migraine	0.00645	0.287	CrCbGaD
Amcinonide—ANXA1—Signaling by GPCR—RAMP1—migraine	0.00634	0.00897	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CALCRL—migraine	0.00634	0.00897	CbGpPWpGaD
Amcinonide—NR3C1—Signaling events mediated by HDAC Class II—ESR1—migraine	0.00617	0.00874	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptors—ESR1—migraine	0.00617	0.00874	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (q) signalling events—HTR2A—migraine	0.00615	0.0087	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00581	0.00823	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.0055	0.00779	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR1B—migraine	0.00544	0.0077	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.00537	0.0076	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR1A—migraine	0.00523	0.00741	CbGpPWpGaD
Amcinonide—Fluoxymesterone—ESR1—migraine	0.00523	0.233	CrCbGaD
Amcinonide—ANXA1—GPCR ligand binding—TAC1—migraine	0.00515	0.0073	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—NPS—migraine	0.00515	0.0073	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR1D—migraine	0.00507	0.00718	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR2C—migraine	0.00506	0.00716	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—EDNRA—migraine	0.00492	0.00696	CbGpPWpGaD
Amcinonide—NR3C1—Nuclear Receptor transcription pathway—ESR1—migraine	0.00488	0.0069	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CALCA—migraine	0.00473	0.0067	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR2B—migraine	0.00472	0.00668	CbGpPWpGaD
Amcinonide—NR3C1—head—migraine	0.00465	0.0171	CbGeAlD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—migraine	0.00463	0.00655	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR1D—migraine	0.00461	0.00652	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—HTR7—migraine	0.00443	0.00627	CbGpPWpGaD
Amcinonide—NR3C1—nervous system—migraine	0.0044	0.0162	CbGeAlD
Amcinonide—ANXA1—Signaling by GPCR—HTR2B—migraine	0.00428	0.00606	CbGpPWpGaD
Amcinonide—NR3C1—central nervous system—migraine	0.00424	0.0156	CbGeAlD
Amcinonide—NR3C1—cerebellum—migraine	0.00414	0.0153	CbGeAlD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.00407	0.00577	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TNF—migraine	0.00382	0.00541	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR1A—migraine	0.00379	0.00537	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—ESR1—migraine	0.00379	0.00536	CbGpPWpGaD
Amcinonide—Dexamethasone—PGR—migraine	0.00375	0.167	CrCbGaD
Amcinonide—ANXA1—Signaling Pathways—RAMP1—migraine	0.00374	0.0053	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CALCRL—migraine	0.00374	0.0053	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TAC1—migraine	0.00373	0.00529	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—migraine	0.00366	0.00518	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—FOS—migraine	0.00341	0.00483	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—migraine	0.00337	0.00477	CbGpPWpGaD
Amcinonide—NR3C1—brain—migraine	0.00337	0.0124	CbGeAlD
Amcinonide—ANXA1—GPCR ligand binding—HTR2A—migraine	0.0031	0.00439	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR1B—migraine	0.00307	0.00435	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—migraine	0.00304	0.0043	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—migraine	0.00301	0.00426	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR1A—migraine	0.00296	0.00419	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—TAC1—migraine	0.00291	0.00412	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—NPS—migraine	0.00291	0.00412	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR2C—migraine	0.00286	0.00404	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR1B—migraine	0.00279	0.00395	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—EDNRA—migraine	0.00278	0.00393	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR1D—migraine	0.00272	0.00385	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR1A—migraine	0.00269	0.0038	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CALCA—migraine	0.00268	0.00379	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—migraine	0.00266	0.00376	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—TAC1—migraine	0.00265	0.00374	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—NPS—migraine	0.00265	0.00374	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TNF—migraine	0.0026	0.00368	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR2C—migraine	0.00259	0.00367	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR2B—migraine	0.00253	0.00358	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EDNRA—migraine	0.00252	0.00357	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR7—migraine	0.0025	0.00354	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CALCA—migraine	0.00243	0.00344	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR7—migraine	0.00227	0.00322	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—migraine	0.00225	0.00318	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—LRP1—migraine	0.00223	0.00315	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—HTR2A—migraine	0.00175	0.00248	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH4—migraine	0.00172	0.00244	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH4—migraine	0.00171	0.00242	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR1B—migraine	0.00165	0.00233	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HTR2A—migraine	0.00159	0.00225	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR1A—migraine	0.00159	0.00225	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—PGR—migraine	0.00158	0.00223	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PGR—migraine	0.00156	0.00221	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TAC1—migraine	0.00156	0.00221	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NPS—migraine	0.00156	0.00221	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR2C—migraine	0.00153	0.00217	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EDNRA—migraine	0.00149	0.00211	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—NOTCH3—migraine	0.00147	0.00208	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NOTCH3—migraine	0.00145	0.00206	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CALCA—migraine	0.00144	0.00203	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR7—migraine	0.00134	0.0019	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TGFBR2—migraine	0.00116	0.00164	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—TNF—migraine	0.00112	0.00158	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—TNF—migraine	0.000966	0.00137	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HTR2A—migraine	0.00094	0.00133	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—ESR1—migraine	0.000842	0.00119	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ESR1—migraine	0.000834	0.00118	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH4—migraine	0.00083	0.00118	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—PGR—migraine	0.00076	0.00108	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—NOTCH3—migraine	0.000706	0.001	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—ESR1—migraine	0.000406	0.000574	CbGpPWpGaD
